scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1041999084 |
P356 | DOI | 10.1186/S13071-016-1932-4 |
P932 | PMC publication ID | 5217559 |
P698 | PubMed publication ID | 28057055 |
P50 | author | Liwang Cui | Q60429811 |
Takafumi Tsuboi | Q63860522 | ||
P2093 | author name string | Fei Liu | |
Qi Fan | |||
Enjie Luo | |||
Wenqi Zheng | |||
Yaming Cao | |||
Qingyang Liu | |||
Yiwen He | |||
Gregory B Humphreys | |||
P2860 | cites work | Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission | Q21134576 |
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria | Q22061872 | ||
Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 | ||
Characterization of a new phosphatase from Plasmodium | Q27670486 | ||
A NIMA-related protein kinase is essential for completion of the sexual cycle of malaria parasites | Q27972563 | ||
Genome-wide functional analysis of Plasmodium protein phosphatases reveals key regulators of parasite development and differentiation | Q27972615 | ||
Characterisation of Plasmodium invasive organelles; an ookinete microneme proteome | Q27972689 | ||
Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine | Q27974539 | ||
A comprehensive evaluation of rodent malaria parasite genomes and gene expression | Q28250679 | ||
A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses | Q28301446 | ||
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity | Q28740771 | ||
The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro | Q30039034 | ||
Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei | Q30043378 | ||
Reverse genetics screen identifies six proteins important for malaria development in the mosquito | Q30046142 | ||
SOAP, a novel malaria ookinete protein involved in mosquito midgut invasion and oocyst development | Q30046679 | ||
Plasmodium invasion of mosquito cells: hawk or dove? | Q44145510 | ||
Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopes | Q44146493 | ||
Ookinete antigens of Plasmodium berghei. Appearance on the zygote surface of an Mr 21 kD determinant identified by transmission-blocking monoclonal antibodies. | Q44146592 | ||
The development of Plasmodium ookinetes in vitro: an ultrastructural study including a description of meiotic division | Q44153021 | ||
Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiation in vivo | Q44169602 | ||
A semi-empirical method for prediction of antigenic determinants on protein antigens | Q52466148 | ||
High efficiency transfection of Plasmodium berghei facilitates novel selection procedures | Q30080002 | ||
Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230. | Q30390705 | ||
Vital functions of the malarial ookinete protein, CTRP, reside in the A domains | Q30581460 | ||
A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli | Q33485233 | ||
A research agenda for malaria eradication: vaccines | Q33818046 | ||
Child mortality and malaria transmission intensity in Africa | Q34207756 | ||
The systematic functional analysis of Plasmodium protein kinases identifies essential regulators of mosquito transmission | Q34293946 | ||
Transmission-blocking vaccines. | Q34680152 | ||
P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions | Q34729130 | ||
Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax | Q35088997 | ||
N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity | Q35138720 | ||
A proteomic analysis of malaria biology: integration of old literature and new technologies | Q35975136 | ||
Evolution of the Transmission-Blocking Vaccine Candidates Pvs28 and Pvs25 in Plasmodium vivax: Geographic Differentiation and Evidence of Positive Selection | Q36062237 | ||
Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants | Q36267184 | ||
Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito | Q36351262 | ||
In vitro formation of ookinetes and functional maturity of Plasmodium berghei gametocytes | Q36411839 | ||
Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 | ||
The microneme proteins CTRP and SOAP are not essential for Plasmodium berghei ookinete to oocyst transformation in vitro in a cell free system | Q36718587 | ||
Malaria transmission-blocking vaccines: the bonus of effective malaria control | Q36785468 | ||
Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei | Q36958620 | ||
Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax | Q37025716 | ||
Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings | Q37119364 | ||
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates | Q37170062 | ||
An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines | Q37243605 | ||
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia | Q37253966 | ||
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite | Q37583147 | ||
Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding | Q37713285 | ||
Toward the development of effective transmission-blocking vaccines for malaria | Q38322553 | ||
Naturally acquired immunity to sexual stage P. falciparum parasites. | Q38689928 | ||
Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates | Q39018502 | ||
A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies | Q39467691 | ||
Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission | Q39679346 | ||
Copolymer adjuvants in malaria vaccine development. | Q40747453 | ||
Transmission blocking malaria vaccines: Assays and candidates in clinical development | Q40979878 | ||
von Willebrand Factor A domain-related protein, a novel microneme protein of the malaria ookinete highly conserved throughout Plasmodium parasites | Q42654983 | ||
Transmission blocking malaria vaccines | Q44145217 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Plasmodium berghei | Q65021 |
malaria vaccine | Q6741353 | ||
infectious disease | Q18123741 | ||
PIMMS43 protein | Q56562267 | ||
PIMMS43 protein, putative | Q56717297 | ||
malaria transmission | Q56928847 | ||
PIMMS43 protein, putative | Q59749164 | ||
PIMMS43 protein, putative | Q59881727 | ||
PIMMS43 protein | Q59916944 | ||
PIMMS43 protein, putative | Q59959833 | ||
PIMMS43 protein, putative | Q59982378 | ||
PIMMS43 protein, putative | Q59982760 | ||
PIMMS43 protein, putative | Q59982832 | ||
PIMMS43 protein, putative | Q60000250 | ||
PIMMS43 protein, putative | Q60008073 | ||
PIMMS43 protein, putative | Q61616988 | ||
ookinete | Q123923963 | ||
P304 | page(s) | 8 | |
P577 | publication date | 2017-01-05 | |
P1433 | published in | Parasites and Vectors | Q7135941 |
P1476 | title | Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate | |
P478 | volume | 10 |
Q56562267 | PIMMS43 protein |
Q59916944 | PIMMS43 protein |
Q56717297 | PIMMS43 protein, putative |
Q59749164 | PIMMS43 protein, putative |
Q59881727 | PIMMS43 protein, putative |
Q59959833 | PIMMS43 protein, putative |
Q59982378 | PIMMS43 protein, putative |
Q59982760 | PIMMS43 protein, putative |
Q59982832 | PIMMS43 protein, putative |
Q60000250 | PIMMS43 protein, putative |
Q60008073 | PIMMS43 protein, putative |
Q61616988 | PIMMS43 protein, putative |
Q90732916 | An MFS-Domain Protein Pb115 Plays a Critical Role in Gamete Fertilization of the Malaria Parasite Plasmodium berghei |
Q56358374 | Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential |
Q60922149 | Druggable Targets in Cyclic Nucleotide Signaling Pathways in Apicomplexan Parasites and Kinetoplastids against Disabling Protozoan Diseases in Humans |
Q92358725 | Malaria.tools-comparative genomic and transcriptomic database for Plasmodium species |
Q58606303 | Metanetwork Transmission Model for Predicting a Malaria-Control Strategy |
Q90281173 | PIMMS43 is required for malaria parasite immune evasion and sporogonic development in the mosquito vector |
Q59923959 | The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes |
Search more.